ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 136 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 162 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 162 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 162 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 162 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -85.7% | 162 | -86.1% | 0.00% | -100.0% |
| Q3 2017 | $7,000 | +600.0% | 1,162 | +617.3% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 162 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 162 | -20.2% | 0.00% | – |
| Q3 2016 | $1,000 | – | 203 | +395.1% | 0.00% | – |
| Q2 2016 | $0 | – | 41 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |